Biopharm SpA

Algeria Health

Biopharm is one of the leading local companies in the Algerian pharmaceutical market. The company is estimated to have around 12% share of the Algerian pharmaceutical import and distribution market.

We are invested in Biopharm SpA through African Development Partners I, which is managed by Development Partners International. For further information on the fund, the fund manager, and the expected impact of the fund’s investment, click here.

Key facts

Status:
Active
Region

Since 2012, we’ve only invested in Africa and South Asia. Investments outside these regions are from our pre-2012 portfolio.

:
Africa, North Africa
Countries:
Algeria
Sector

We have seven priority sectors. However, we continue to invest outside these sectors, largely in the most challenging regions, as new investment supporting any sector helps to underpin the private sector, and create jobs and livelihoods for people.

:
Health
Investment type

We provide capital in three broad ways: direct equity, debt, and intermediated equity (principally through investment funds).

:
Intermediated investment
Fund:
African Development Partners I
Fund Manager:
Development Partners International
Start date

For direct investments, this is the date CDC committed capital to the business or project.

For funds, this is the date that CDC committed capital to the fund.

For underlying fund investments, this is the date that the fund invested capital into the business.e

:
March 2013
Domicile

This is the investee company’s place of incorporation; or a fund’s jurisdiction.

:
Algeria